These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4960554)

  • 61. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Inoculability and drug resistance of Mycobacterium tuberculosis in patients with peripheral tuberculous lymphadenitis].
    Maskeev KM; Sidorkina EV; Krivtsova AE; Kim D; Eretina NG
    Probl Tuberk; 1971; 49(8):81-5. PubMed ID: 5005005
    [No Abstract]   [Full Text] [Related]  

  • 63. [Primary resistance of Mycobacterium tuberculosis in the province of Vizcaya].
    Echeverría MJ; Ayarza R; Jiménez MS; López de Goicoechea MJ; Berdonces P; Ibarretxebea AB
    Rev Esp Quimioter; 1999 Jun; 12(2):152-3. PubMed ID: 10562678
    [No Abstract]   [Full Text] [Related]  

  • 64. A quantitative method of determination of mycobacterium tuberculosis resistance to classical antituberculous drugs.
    Zduńczyk-Pawelek H; Kostrzewska K; Blitek-Golc D
    Pol Med J; 1966; 5(4):900-6. PubMed ID: 4960780
    [No Abstract]   [Full Text] [Related]  

  • 65. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. 2].
    Yamamoto M
    Kekkaku; 1970 Nov; 45(11):359-66. PubMed ID: 4992936
    [No Abstract]   [Full Text] [Related]  

  • 66. [Antituberculous action of a new antibiotic, Lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents].
    Tsukamura M; Mizuno S; Yamamoto M
    Kekkaku; 1970 Aug; 45(8):263-72. PubMed ID: 4989999
    [No Abstract]   [Full Text] [Related]  

  • 67. [Primary resistance to 2d order chemotherapeutic agents].
    Schröder KH
    Beitr Klin Erforsch Tuberk Lungenkr; 1967; 136(1):271-3. PubMed ID: 4966081
    [No Abstract]   [Full Text] [Related]  

  • 68. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
    Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
    Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Observations on the chemo-antibiotic-resistance in vitro of more than 400 strains of Mycobacterium tuberculosis recently isolated].
    Spaziante G; Caroli G; Mazzarone R
    Riv Ital Ig; 1966; 26(5):512-34. PubMed ID: 4967921
    [No Abstract]   [Full Text] [Related]  

  • 70. [Acquired resistance of M tuberculosis to the antitubercular drugs in Chile from 1988 to 1991].
    Guzmán AM; García P; Valenzuela MT; Piffardi S; Lepe R; Velasco M; Vergara MI
    Rev Med Chil; 1993 Nov; 121(11):1269-73. PubMed ID: 8191133
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Drug resistant Mycobacterium tuberculosis.
    Lim VK
    Med J Malaysia; 1993 Jun; 48(2):97-8. PubMed ID: 8350810
    [No Abstract]   [Full Text] [Related]  

  • 72. [L-transformation of Mycobacterium tuberculosis as one of the sources of formation of drug resistant strains].
    Kochemasova ZN; Dykhno MM; Kassirskaia NG; Bakanova DIa
    Vestn Akad Med Nauk SSSR; 1969; 24(5):91-4. PubMed ID: 4985325
    [No Abstract]   [Full Text] [Related]  

  • 73. Is second-line anti-tuberculosis drug susceptibility testing reliable?
    Kim SJ; Espinal MA; Abe C; Bai GH; Boulahbal F; Fattorin L; Gilpin C; Hoffner S; Kam KM; Martin-Casabona N; Rigouts L; Vincent V
    Int J Tuberc Lung Dis; 2004 Sep; 8(9):1157-8. PubMed ID: 15455606
    [No Abstract]   [Full Text] [Related]  

  • 74. [Evaluation of secondary chemoresistance of Koch bacillus at the present time].
    Jemna I; Lego I
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(4):243-4. PubMed ID: 6278569
    [No Abstract]   [Full Text] [Related]  

  • 75. [Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3].
    Nakai H; Maekawa N; Nakanishi M; Kawai M; Naito M
    Bull Chest Dis Res Inst Kyoto Univ; 1971 Jan; 4(1):15-24. PubMed ID: 5005481
    [No Abstract]   [Full Text] [Related]  

  • 76. [Studies of the polychemoresistance of Mycobacterium tuberculosis].
    Curci G; De Franciscis V; Giuliano V
    Arch Monaldi; 1970; 25(2):99-114. PubMed ID: 4994908
    [No Abstract]   [Full Text] [Related]  

  • 77. [Primary resistance of Mycobacterium tuberculosis].
    Blancarte L; Anzaldo de Jaime G; Balandrano S
    Salud Publica Mex; 1982; 24(3):321-7. PubMed ID: 6815813
    [No Abstract]   [Full Text] [Related]  

  • 78. [Determination of drug sensitivity of Mycobacterium tuberculosis by means of potassium tellurite].
    Kovalev GK
    Antibiotiki; 1969 Apr; 14(4):323-5. PubMed ID: 4977639
    [No Abstract]   [Full Text] [Related]  

  • 79. [Resistance of tuberculosis mycobacteria isolated from resected lungs].
    Usov II; Belousov AV
    Probl Tuberk; 1967; 45(12):68. PubMed ID: 4974358
    [No Abstract]   [Full Text] [Related]  

  • 80. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. Influence of background factors, factors regarding the method of treatment and the course of the disease on the emergence of drug resistance].
    Yamamoto M; Nakamura H; Inagaki H
    Kekkaku; 1970 Oct; 45(10):349-57. PubMed ID: 4991618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.